The Joint Commission to resume surveys this month
Regular surveys and reviews by The Joint Commission will resume this month, the commission announced last week.
TJC, which had suspended surveys during the COVID-19 pandemic, said the surveys will resume with extra safety changes in place, including identifying and prioritizing low-risk areas in which it can safely survey. Specifically, TJC said the process will include social distancing practices, limits on the size of group sessions, the use of masks and personal protective equipment, and, when appropriate, the use of technology, such as video conferencing.
The surveys’ focus will be on how organizations adapted to the COVID-19 pandemic and review current practices; they will not retroactively review compliance.
Related News Articles
Headline
An op-ed published July 9 in Modern Healthcare written by AHA President and CEO Rick Pollack and Catholic Health Association President and CEO Sr. Mary Haddad…
Headline
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
The Federal Trade Commission April 23 voted 3-2 to issue a final rule that would ban as an unfair method of competition contractual terms that prohibit workers…
Blog
A recent Modern Healthcare article misleadingly suggests that hospitals and health systems provided less charity care between 2020 and 2023. The truth is much…
Headline
On Oct. 31 at 1 p.m. ET, the Food and Drug Administration will host a webinar to review its recent proposed rule for laboratory developed tests,…
Perspective
All hospitals and health systems provide an oasis of care, compassion and healing to the patients and communities they serve.
They offer a range of services…